Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Med Virol ; 96(5): e29621, 2024 May.
Article in English | MEDLINE | ID: mdl-38654686

ABSTRACT

Mpox is a zoonotic disease historically reported in Africa. Since 2003, limited outbreaks have occurred outside Africa. In 2022, the global spread of cases with sustained interhuman transmission and unusual disease features raised public health concerns. We explore the mpox outbreak in Rio de Janeiro (RJ) state, Brazil, in an observational study of mpox-suspected cases from June to December 2022. Data collection relied on a public healthcare notification form. Diagnosis was determined by MPXV-PCR. In 46 confirmed cases, anti-OPXV IgG was determined by ELISA, and seven MPXV genomes were sequenced. A total of 3095 cases were included, 816 (26.3%) with positive MPXV-PCR results. Most positive cases were men in their 30 s and MSM. A total of 285 (34.9%) MPXV-PCR+ patients live with HIV. Eight were coinfected with varicella-zoster virus. Anogenital lesions and adenomegaly were associated with the diagnosis of mpox. Females and individuals under 18 represented 9.4% and 5.4% of all confirmed cases, respectively, showing higher PCR cycle threshold (Ct) values and fewer anogenital lesions compared to adult men. Anti-OPXV IgG was detected in 29/46 (63.0%) patients. All analyzed sequences belonged to clade IIb. In RJ state, mpox presented a diverse clinical picture, represented mainly by mild cases with low complication rates and prominent genital involvement. The incidence in females and children was higher than usually reported. The observation of a bimodal distribution of Ct values, with few positive results, may suggest the need to review the diagnostic criteria in these groups.


Subject(s)
Disease Outbreaks , Humans , Brazil/epidemiology , Male , Female , Adult , Young Adult , Adolescent , Middle Aged , Animals , Zoonoses/epidemiology , Zoonoses/virology , Herpesvirus 3, Human/genetics , Herpesvirus 3, Human/isolation & purification , Child , HIV Infections/epidemiology , HIV Infections/virology , Antibodies, Viral/blood , Aged , Immunoglobulin G/blood
2.
Biochem Eng J ; 186: 108537, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35874089

ABSTRACT

Serological tests detect antibodies generated by infection or vaccination, and are indispensable tools along different phases of a pandemic, from early monitoring of pathogen spread up to seroepidemiological studies supporting immunization policies. This work discusses the development of an accurate and affordable COVID-19 antibody test, from production of a recombinant protein antigen up to test validation and economic analysis. We first developed a cost-effective, scalable technology to produce SARS-COV-2 spike protein and then used this antigen to develop an enzyme-linked immunosorbent assay (ELISA). A receiver operator characteristic (ROC) analysis allowed optimizing the cut-off and confirmed the high accuracy of the test: 98.6% specificity and 95% sensitivity for 11+ days after symptoms onset. We further showed that dried blood spots collected by finger pricking on simple test strips could replace conventional plasma/serum samples. A cost estimate was performed and revealed a final retail price in the range of one US dollar, reflecting the low cost of the ELISA test platform and the elimination of the need for venous blood sampling and refrigerated sample handling in clinical laboratories. The presented workflow can be completed in 4 months from first antigen expression to final test validation. It can be applied to other pathogens and in future pandemics, facilitating reliable and affordable seroepidemiological surveillance also in remote areas and in low-income countries.

3.
J Exp Med ; 219(9)2022 09 05.
Article in English | MEDLINE | ID: mdl-35796685

ABSTRACT

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be a global problem in part because of the emergence of variants of concern that evade neutralization by antibodies elicited by prior infection or vaccination. Here we report on human neutralizing antibody and memory responses to the Gamma variant in a cohort of hospitalized individuals. Plasma from infected individuals potently neutralized viruses pseudotyped with Gamma SARS-CoV-2 spike protein, but neutralizing activity against Wuhan-Hu-1-1, Beta, Delta, or Omicron was significantly lower. Monoclonal antibodies from memory B cells also neutralized Gamma and Beta pseudoviruses more effectively than Wuhan-Hu-1. 69% and 34% of Gamma-neutralizing antibodies failed to neutralize Delta or Wuhan-Hu-1. Although Class 1 and 2 antibodies dominate the response to Wuhan-Hu-1 or Beta, 54% of antibodies elicited by Gamma infection recognized Class 3 epitopes. The results have implications for variant-specific vaccines and infections, suggesting that exposure to variants generally provides more limited protection to other variants.


Subject(s)
COVID-19 , SARS-CoV-2 , Antibodies, Neutralizing , Antibodies, Viral , Antibody Formation , Humans , Membrane Glycoproteins/metabolism , Neutralization Tests , Spike Glycoprotein, Coronavirus , Viral Envelope Proteins
4.
Brasília; IPEA; 2020. 16 p. graf.(Nota Técnica / IPEA. Diset, 76).
Monography in Portuguese | ECOS, LILACS | ID: biblio-1145221

ABSTRACT

Esta nota técnica tem o objetivo de realizar uma análise sobre o perfil socioeconômico da população que teve confirmada a infecção pela Covid-19 no estado do Rio de Janeiro e investigar em que medida determinadas características socioeconômicas afetam as chances de morrer da doença. Para isso, serão utilizadas informações socioeconômicas individualizadas disponíveis para o conjunto dos trabalhadores formais do estado.


Subject(s)
Cause of Death , Coronavirus , Endemic Diseases , Socioeconomic Factors , Coronavirus Infections , Death , Pandemics , Brazil
5.
Front Immunol ; 9: 3147, 2018.
Article in English | MEDLINE | ID: mdl-30687336

ABSTRACT

Background: Pulmonary tuberculosis (PTB) can lead to lung tissue damage (LTD) and compromise the pulmonary capacity of TB patients that evolve to severe PTB. The molecular mechanisms involved in LTD during anti-tuberculous treatment (ATT) remain poorly understood. Methods and findings: We evaluated the role of neutrophil extracellular trap (NET) and the occurrence of LTD through chest radiographic images, the microbial load in sputum, and inflammatory serum profile (IL-12p40/p70, IL-8, IL-17A, IL-23, VEGF-A, MMP-1, and -8, galectin-3, citrunillated histone H3-cit-H3, alpha-1-antitrypsin-α1AT, C-reactive protein-CRP and albumin) in a cohort of 82 PTB patients before and after 60 days of ATT. Using univariate analysis, LTD was associated with neutrophilia and increase of several inflammatory proteins involved in the neutrophil-mediated response, being cit-H3 the more related to the event. In the multivariate analysis, neutrophilia and cit-H3 appear as directly related to LTD. The analysis of the ROC curve at day 60 presented AUC of 0.97 (95.0% CI 0.95-1). Interestingly, at day 0 of ATT, these biomarkers demonstrated fine relation with LTD showing an AUC 0.92 (95.0% CI 0.86-0.99). Despite of that, the same molecules have no impact in culture conversion during ATT. Conclusions: Our data revealed that NETs may play a key role in the pathway responsible for non-specific inflammation and tissue destruction in PTB. High level of cit-H3 and low level of α1AT was observed in the serum of severe TB patients, suggesting a breakdown in the intrinsic control of NET-driven tissue damage. These data show a new insight to knowledge TB immunopathogenesis, the role of neutrophil and NET pathway. Likewise, we identified possible biomarkers to screening of PTB patients eligible to adjuvants therapies, as anti-inflammatories and alpha-1-antitrypsin.


Subject(s)
Extracellular Traps/immunology , Extracellular Traps/metabolism , Neutrophil Infiltration , Tuberculosis, Pulmonary/etiology , Tuberculosis, Pulmonary/metabolism , alpha 1-Antitrypsin/metabolism , Adult , Biomarkers , Cohort Studies , Comorbidity , Cytokines/metabolism , Female , Humans , Inflammation Mediators/metabolism , Male , Metalloproteases/metabolism , Middle Aged , Neutrophils/immunology , Neutrophils/metabolism , Neutrophils/pathology , Radiography, Thoracic , Severity of Illness Index , Thrombocytosis/blood , Tuberculosis, Pulmonary/diagnostic imaging , Tuberculosis, Pulmonary/pathology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...